Hot Take: Dr. Oz Defends Medical Marijuana on “Fox & Friends”

Anyone tuning in to Fox & Friends this week was treated to an awkward moment courtesy of Dr. Oz, when he went off-script after plugging his upcoming interview with Ivanka Trump and launched into an impassioned defense of medical marijuana.

“Can I ask you one thing? I talked about the opioid epidemic, but the real story is the hypocrisy around medical marijuana. And just really quickly, medical marijuana – people think it’s a gateway drug to narcotics but it may be the exit drug to get us out of the narcotic epidemic. But we’re not allowed, we’re not allowed to study it, because it’s a schedule I drug. And personally, I believe it could help.”

“Wow,” co-host Steve Doocy intoned, visibly tense. “Hadn’t heard that before.” He reminded viewers to watch Oz’s show and cut to commercial break, clearly wishing the cardiologist had taken co-host Brian Kilmeade’s cue to end the segment twenty seconds prior.Read More »

Advertisements

Donald Trump on Drugs: Election 2016, Part I

In response to Donald Trump’s sniffly debate performances over the last month-and-a-half of the 2016 presidential campaign, the Twittersphere erupted in wild speculation that the alleged billionaire had prepared with lines other than his taking points. “Notice Trump sniffling all the time. Coke user?” ventured Howard Dean, former chair of the Democratic National Committee, one-time presidential candidate, and, not incidentally, licensed medical doctor. Others consulted drug authorities, of a sort. Self-described cocaine “expert” Carrie Fisher told a curious fan that she “ABSOLUTEY” thought Trump appeared like a “coke head.”

Dean’s jab, relatively on par with some of Trump’s own supposed zingers, was immediately scrutinized and dismissed by commentators. But it is curious that drugs have only sporadically entered the national conversation when, in recent years, opioid overdoses – usually in combination with other substances – routinely kill about 1,000 Americans a month. Moreover, four states are voting on medical marijuana and five, including the hugely influential California, may fully legalize.

While Trump probably doesn’t toot key bumps before going onstage, it is worth considering in a serious way what a potential future commander-in-chief believes about an issue near and dear to Points readers: drug policy. What follows is an attempted breakdown of Trump’s position on the three key topics mentioned above. I say “attempted” because, like with most things, his often contradictory stance on drugs is characteristically hard to pin down.

Medical Marijuana

Sitting for an interview on the O’Reilly Factor in February, Trump displayed some surprising compassion for others after host Bill O’Reilly called medical marijuana a “ruse”: “But I know people that have serious problems and they did that, they really – it really does help them,” Trump professed.

He didn’t offer any clarifying details but said that he was “in favor of it a hundred percent.”

Of course, Trump would take no action for or against such an initiative at the federal level. “Marijuana is such a big thing. I think medical should happen, right? Don’t we agree? I think so. And then I really believe we should leave it up to the states,” he told a Reno crowd during the primaries last year.

Recreational Marijuana

Still toeing the small-federal-government line of the party that gave him its nomination, Trump similarly left recreational weed for states to decide. I think.

During a debate last summer, he opined that “[regulating marijuana] is bad. Medical marijuana is another thing, but I think it’s bad and I feel strongly about that.” When pressed by the moderator about states’ rights to set their own policy, he verbally shrugged: “If they vote for it, they vote for it. But they’ve got a lot of problems going on right now in Colorado – some big, big problems.” (Again, no specifics.)

Later, at the same rally he proclaimed medical a state issue, he softened his tone. “In terms of marijuana and legalization, I think that should be a state issue, state-by-state.”

Notably, during the cultural hysteria of the crack epidemic, Trump supported full legalization. “We’re losing badly [bigly?] the War on Drugs. You have to legalize drugs to win that war. You have to take the profit away from these drug czars.” When pressed about his 1990 statement last year, Trump must have misremembered. “I said it’s something that should be studied and should continue to be studied. But it’s not something I’d be willing to do right now. I think it’s something that I’ve always said maybe it has to be looked at because we do such a poor job of policing. We don’t want to build walls. We don’t want to do anything. And if you’re not going to do the policing, you’re going to have to start thinking about other alternatives. But it’s not something I would want to do.”

Opioid Addiction

Trump calls the problem of opioid addiction “tremendous.”

He may very well believe that his proposed wall on the U.S.-Mexico border will stem the tide of heroin into the states, but traffickers are responding to demand cultivated domestically.

In any case, don’t expect any enlightened harm reduction rhetoric from a man who idolizes Vladimir Putin. Earlier this year, hardline Russian delegates to the United Nations General Assembly’s Special Session on Drugs insisted that that very term – “harm reduction” – appear nowhere in the resulting document outlining the contours of future global drug policy. Among the common treatment modalities in Russia are reportedly hypnosis, flogging, and comatose electroshock therapy. Unsurprisingly, addiction and HIV transmission through injection drug use are pressing social problems in Russia.

It remains unclear whether the experience of Trump’s own brother Freddy, who died addicted to alcohol in 1981, inspires any empathy for the plight of users. He did, however, give a second chance to at least one Miss USA accused of drug use.

I guess he’ll keep us in suspense!

Check back next week for part II of Point’s election 2016 candidate breakdown.

 

Trick or Treat? On Laced Candy and Other Drug Myths

fnd-halloween-candy-bucket_s4x3_lg
Beware… or don’t. 

This year, medical marijuana is on the ballot in my home state of Florida, and it’s likely to pass: the latest statewide poll shows 77 percent of Floridians support the proposed constitutional amendment.

But the remaining 33 percent aren’t taking this lying down. On Monday, some county sheriffs held a press conference ostensibly on Halloween safety. Instead, surrounded by costumed children for full effect, they warned citizens about the supposed risk of marijuana edibles being passed out to unsuspecting youth.

14680716_1294900980554316_7411870518239895113_n
Courtesy, Florida Sheriff’s Association

If you rolled your eyes, you’re not alone. Several news outlets immediately speculated that the press conference was an effort to rally anti-marijuana enthusiasm before election day. None of the law enforcement officials present could identify a prior case in the state, though they insisted the “threat” is real.

Florida parents likely have little to fear next Monday night, regardless of the imminent election results. Even in newly legal states, no one (well, no child) found a “Pot Tart” or “Zonka Bar” in their Halloween haul last year. (And, when you think about it, how many people were handing out chocolate liquor cordials before then?) Plus, the idea of adulterated candy is nothing new. Snopes identified variants of this trope, including poisoned, razor-containing, or intoxicating children’s confections, going back decades. Only a few spuriously related incidences have ever been documented, and those have little or no connection to the actual goings-on of the holiday.

14556666_1294901093887638_3117202510826900307_o

But drug myths like laced Halloween candy can be read as classic examples of folklore, or what scholars call cultural sets of beliefs shared to rationalize complex, unknown, or unknowable phenomenon. And folklorists will tell you these kinds of urban legends aren’t just for debunking. In her book on rumor in African American culture, I Heard It Through the Grapevine, Black folklorist Patricia Turner related that these claims are often not representative of “typical” beliefs. Instead, they offer novel insights into “pattern[s] of thought” through “an under-studied folk tradition.”

Folklorists like Turner, Gary Alan Fine, and Jan Harold Brunvand have for decades implored us, not to question the “objective” “truth” of these ideas, but to analyze what anxieties they reveal within their constituencies. It doesn’t necessarily matter if, as some profess, the CIA introduced crack to American cities, or methadone causes cancer, or suburban stoners would divvy up their stash with neighborhood kids. But those repeated ideas, true or false, sincere or not, have real implications.

What anxieties can you identify in this case, and in our mythic drug discourse more broadly?

 

THE FUTURE OF UK MEDICAL MARIJUANA REMAINS BLURRY BUT THERE ARE LESSONS TO TAKE AWAY FROM CANADA

Editor’s Note: Today’s post is cross-hosted at Points and Cannabis Life Network. Contact author Lucas Richert at lucasrichert@strath.ac.uk. 

From 2014–2016, Canadian health authorities were forced to address the issue of medical marijuana, even as activist groups and industry sought to influence the decision-making process and its place in the medical marketplace. First, the system was privatized, then issues of use and access, not to mention the full-on legalization of recreational marijuana, dominated headlines.

In light of last week’s shocking medical marijuana report, the policy debate will certainly grow more heated here in the UK. The All Party Parliamentary Group on Drug Policy Reform stated there is “good evidence” cannabis can help alleviate the symptoms of several health conditions, including chronic pain and anxiety. According to Prof Mike Barnes, a leading consultant neurologist who contributed to the report, “We must legalise access to medical cannabis as a matter of urgency.”

In a recently co-edited series on Canadian cannabis called Waiting to Inhale, it became clear that medical marijuana was a supremely complex policy issue. Some of the questions included, but were not limited to, the tenuous balance between consumers and regulators, Canadian physicians as unwanted gatekeepers, marijuana as a measure (and potential leveller) of inequities, and the major struggles between Big Cannabis and craft cannabis.

Looking ahead, the UK can learn lessons from other countries, including Canada.

Background: Canadian medical cannabis

Medical marijuana has been available in Canada since 2001, after the Canadian Court of Appeal declared that sufferers from epilepsy, AIDS, cancer and other ailments had a constitutional right to light up. Prohibition of this “medicine” was, in short, unconstitutional.

The original regulation that allowed patients to access medical marijuana in Canada was enacted in 2001 and called the Marihuana Medical Access Regulations (MMAR). It allowed patients to possess dried marijuana flower/bud with a license issued by the government, provided that the application was signed off by a physician.

One strain of medicine was available for purchase from one single government supplier, Prairie Plant Systems, but optional licenses were available for patients to grow their own plants or to designate a grower to supply medicine to them.

The MMAR was repealed and replaced by the Marihuana for Medical Purposes Regulations (MMPR), enacted on Apr. 1, 2014. With this, medical marijuana was officially opened for business. And the new rules generated a craze as dozens of new entrants jumped into the marketplace.

As of Aug. 24, 2016 the MMPR was replaced with the Access to Cannabis for Medical Purposes Regulation (ACMPR). These new regulations included legislation that satisfied the latest Supreme Court decision to allow patients who possess a prescription from a doctor to grow their own medicine.

During this period, certain problems have hindered the medical marijuana industry’s growth in Canada, and Britain could learn from these.

Dispensaries vs. Big Cannabis

These stores and clubs are illegal because they procure and sell their products outside the federal medical marijuana system, which was overhauled and expanded last year to allow industrial-scale production of pot products that are mailed directly to licensed patients.

The pushback against dispensaries has come from national and local law enforcement as well as the Canadian Medical Cannabis Industry Association. Yet, the Cannabis Growers of Canada, a trade association representing “unlicensed” growers and dispensaries, have fought to be included at the table. Along with several other organizations, the CGC has lobbied the government to be included in the new legal regime.

As the New York Times put it, “a lobbying battle is raging between the new entrepreneurs and the licensed medical marijuana producers, who were the only ones allowed to grow and provide the plant under the old regulations. One side complains about being shut out by a politically connected cartel, while the other complains about unfair and damaging competition from those who are breaking the law.”

Physicians

Medical marijuana has not approved as a medicine by Health Canada, although there is a growing body of clinical evidence regarding its pain-alleviating effects.

As such, physicians in Canada have struggled with the science and ethics of medical marijuana. At the 147th annual meeting of the Canadian Medical Association in Ottawa last August, many doctors expressed serious reservations about prescribing marijuana.

Some doctors said they felt threatened or intimidated into signing prescriptions, whereas others felt as though patients were shopping for doctors. Worst of all, there were reported cases of malfeasance, where doctors charged their patients for a prescription.

The result is that the CMA remains divided on, if not outright opposed to, being the gatekeepers of medical marijuana.

Workplace Safety and Performance

With more relaxed rules around medical marijuana (along with federal legislation looking to legalize cannabis),employers are wondering whether this will grow as an issue when it comes to pre-employment or on-the-job testing.

Aside from certain industries, such as transportation, most provinces don’t have clear policies or precedents for dealing with medical marijuana.

Besides that, workplace screening of marijuana is a mediocre indicator of performance in the workplace as it doesn’t actually test for impairment. Rather, it tests for by-products excreted from the body after the drug’s been ingested.

Looking ahead, human resource departments will be forced to develop a raft of new policies.

Veterans

The core problem rests with the amount of cannabis veterans are authorized to take. In 2014, Veterans Affairs doubled the amount to 10 grams per day for eligible veterans. Yet, this is twice the amount Health Canada considers safe.

An internal Health Canada document showed that more than five grams has the potential to increase risks to the cardiovascular, pulmonary and immune systems, as well as psychomotor performance and has a chance of increasing the risk of drug dependence.

Ferguson’s office could not find any evidence to support this decision to increase the threshold. Veterans Affairs Minister Kent Hehr expressed shock in March that his department lacked an “informed policy” on the use of medical cannabis, even as the number of claims by veterans for medical marijuana grew more than tenfold over the past two years.

Vaping

The intersection of vaping and medical marijuana has also caused tension. As vaping has moved from a niche presence to mainstream practice, its unregulated nature – at the federal level – poses problems to policy-makers.

For example, the Ontario government exempted medical marijuana users in mid-November from a law that bans the use of e-cigarettes anywhere regular cigarettes are prohibited. These regulations were set to come into effect Jan. 1. This exemption meant medical marijuana users could vape in restaurants, at work or on playgrounds. However, Ontario’s associate health minister Dipika Damerla stated that the government would remove the exemption.

Local governments in various cities recently voted to implement a vaping bans in public spaces, with only a vape shop exemption predicated on “safety” concerns, specifically for the uninitiated e-cigarette user who doesn’t know how to install batteries in the device. But it was also predicated on the notion that buyers should be able to see what they’re getting, which is the same argument made by authorized medical cannabis users about the value of a local pot dispensary.

The Future

Marijuana remains a highly contested medicine for various scientific, political and social reasons. That is obvious.

Policy makers from government, industry leaders, and physicians will face considerable question marks. Cutting through all the haze won’t be an easy task, yet all participants, including the public, would be wise to use recent examples from Canada to light the way.

Holy Smoke: Religious Freedom and Medical Marijuana in the 1990s.

During my visit to the NORML archives, I found a few interesting items on religious uses of marijuana during the 1990s [1]. These were appealing because I remember coming of age during a time when you’d occasionally hear a story about people getting busted for drugs and “claiming religious freedom” to justify their dangerous criminal behavior. I decided to gather these sources expecting that I could work with them at some point.

Frequent readers, have read a few of my thoughts about historical perspectives on motivations for cannabis use and the following will speak to this research interest, but the real motivation for picking these sources back up is NFLer Colin Kaepernick’s recent pre-game protests against abuses of police power. In my own experience, the social media storm seems to boil down to a conflict over who can own the controversy. Meanwhile Kaepernick’s own words about his motivation fail to resonate. In a story twist familiar to drug historians, the failure to understand real motivation obscures and threatens to silence or erase a public act of defiance against social injustice.Read More »

Teaching Points: Teaching the “So What?” in “Marijuana in American History”

Editor’s Note: Today’s post comes to you courtesy of Seth Blumenthal, a Lecturer at Boston University. Contact the author at sblument@bu.edu.

In 1994, the president of the Modern Language Association, Patricia Meyers Spacks, outlined the need to consider “So what?” in higher education. “We get a bad press these days … many believe that we too often devote our efforts to enterprises mattering only to ourselves,” Spacks warned.  “Our research and writing, these critics appear convinced, possess even less value than our teaching. ‘So what?’ echoes loudly around us.”[1] Spacks then suggested a solution:  “We must answer ‘So what?’ as a real rather than a rhetorical question.”  This battle cry to co-opt the critics’ “So what?” applies to disciplines across the humanities that have suffered from a shift toward more focused and vocational training in college. Specifically, while making historical narratives compelling and relevant has always motivated historians’ research and teaching, this cause has become even more urgent with on-going decreases in student enrollment in history courses.

As a lecturer in Boston University’s College of Arts and Sciences writing program, I have attempted to answer this call by teaching the first history course dedicated to cannabis in the United States, “Marijuana in American History.” This course attracts students from a wide array of fields in fulfillment of BU’s required two-semester writing and research sequence. For many students, especially those from disciplines outside of the humanities, taking a course that revolves around writing papers represents a trip to a foreign land. Thus, students’ dismissal of history writing as an arcane and niche enterprise reflects a wider protest that asks “So what?” in its most derisive context, analogous to its evil twin, “Who cares?” In 2007, 2.24 percent of college graduates majored in history, but only 2.02 percent in 2011.[2]  In response, historians have initiated an emphasis on a new pedagogical approach to authentic historical problems or controversies that more accurately reflect the profession’s self-directed historical inquiry to establish an argument’s significance—the “so what?”

In my own teaching, making history relevant is a two pronged strategy. First, the subject, marijuana, is a popular topic that many students (mostly male) are curious about for a variety of reasons (some better than others). This course follows three eras of marijuana politics. First we cover the major controversies surrounding the Anslingerian prohibition years in the 1930s; next, we examine the war on drugs that began in the 1960s; and finally, we research the legalization era that began in the 1990s.  The topic obviously provides a rich cultural history with a dizzying array of sources that engage students but also consider marijuana’s symbolic and political significance. For example, while reliable entertainment, comparing Reefer Madness, Easy Rider, Cheech and Chong’s Up in Smoke and Jeff Spicoli from Fast Times at Ridgemont High provides a fascinating window into Americans’ shifting sentiments about pot and the stoner from the 1930s to the 1980s. While the first two papers ask students to argue about the historical trends in marijuana culture, science and politics, the final assignment embraces the topic’s current controversy and asks students to develop an argument about the reason for the recent growing support for legalization. This assignment gives students free reign to choose their topics, as they write about issues such as marijuana culture and research in social media, women’s roles in the effort, the motivation for racial justice and of course the medicinal movement.

Second, this class shows history as controversy with contemporary implications rather than a list of dates and names. Students analyze political texts such as congressional testimony and Richard Nixon’s tapes to explore the complicated messages and cultural assumptions that informed our policies on drugs. Practicing these historical skills, students quickly learn that as soon as they can formulate a thesis, the “so what?” should also be included.  Why does it matter if we scapegoat the first director of the Federal Bureau of Narcotics, Harry J. Anslinger, for passing the Marijuana Tax Act in 1937? What lessons should we learn from following the rise and fall of the gateway theory? What does millennials’ overwhelming support for legalization say about this generation? All of these questions push students to make the connections between their scholarly argument and its current implications. Beyond the academic pursuit of marijuana history’s larger significance, my students can feel the topic’s controversy outside the classroom.

Soon, the class picked up wider publicity and critics predictably asked why something like this should pass as “college material.” One response to an article USA Today ran on “Marijuana in American History” expressed the abhorrence that many parents shared. “As a parent of a prospective student: STRIKE 1” read one typical reaction.  “This is not something we are looking for in a future college.” As a new hire, I began to question my decision to offer the course. After checking with BU’s public relations office, however, I quickly realized that the positives greatly outweighed the negatives and they reassured me of the university’s support.  In addition, students in my class found the controversy over their course flattering. One even expressed that she felt she was actually a part of history, while another engineering student reflected in his course portfolio, “At this time I think I have far greater perspective on the marijuana issue, but really what I think I got out of this course was a greater appreciation for how the whole ‘liberal arts college’[humanities?] thing can teach you how to think about issues.”  In his paper, he argued that courses like “Marijuana in American History” are necessary, asking: “if marijuana has been legitimized in business, medicine and in politics-why not in academics?”—essentially developing a “so what?” that answered many critics who wondered “who cares”? (Or as one person protested: “And this course will prepare the student to do something?”). Despite the current hostility to the humanities, or perhaps because of it, the history of marijuana is a new and exciting field that can expand undergraduates’ notions of history’s role in changing perceptions of drugs and alcohol in society.

[1] Patricia Meyers Spacks, “Presidential Address 1994: Reality-Our Subject and Discipline,” PMLA, 110 (May, 1995), 350-357.

[2]Robert Townshend, “Data Shows a Decline in History Majors,” Perspectives, 51 (April, 2013); Mills Kelly, “A Looming Disaster for History,” April 12, 2013, edwired ; http://edwired.org/2013/04/12/a-looming-disaster-for-history/.

 

Experimenting with Cannabis: Science and Reefer Madness

Recent work on commodities, particularly Paul Gootenberg’s recent work on cocaine has highlighted the roll of knowledge formation in understanding the dynamics of commodity relationships. In his book, Gootenberg traced the commodity chain of cocaine as it was shaped through political, economic, and intellectual filters in Bolivia, Peru, Germany, the United States and elsewhere. Gootenberg’s work has broadened our understanding of this global commodity over a long period of time, and suggests that the nature of these knowledge filters shift as commodities cross temporal and geographical boundaries.

Historians who study commodities within more limited spacial and temporal boundaries can still find Gootenberg’s work useful. As Michael Pollan suggests in his recent work, The Botany of Desire, the meaning of cannabis was contested at the foundational level – of biology itself – as the plant was molded and shaped for a multiplicity of human uses. Taken together, the historical and intellectual approaches of these and similar studies can help us better understand how, during the first four decades of the twentieth century, cannabis was not merely transformed from an important industrial input to a dangerous recreational drug, but often held both distinctions simultaneously.
Read More »

Fiction Points: Eileen Cronin

CRONINEileen Cronin is a writer and clinical psychologist. Her book Mermaid: A Memoir of Resilience (2014) centers on her search for the truth about her body and the role that the drug thalidomide played in its shape, her childhood in a large Catholic family, her mother’s mental illness, her marriage, and her own struggles with alcohol. In addition to nonfiction, Cronin writes poetry and fiction. Her work has appeared in The Washington Post, Bellevue Literary Review, Los Angeles Times, Third Coast,  and Best American Essays, among other venues. She also writes for The Huffington Post. Mermaid appeared on O, The Oprah Magazine‘s Best Memoirs of 2014 list and Pop Sugar‘s “Must Reads of 2014.” In 2008, Cronin won the Washington Writing Prize for Short Fiction. Her nonfiction has earned her a Pushcart Prize nomination, and her two novels were finalists for the Pirate’s Alley Faulkner Award for Novels-in-Progress. Cronin serves as an assistant editor for Narrative Magazine and lives in Los Angeles. 

Two nuns and a penguin approach you at a bar, and you tell them you’re a writer. When they ask you what you write about, how do you answer?

I can’t help but to notice the resemblance between these folks at the bar. But I don’t ask about that, nor do I tell them that I have written about a nun who looked like a penguin when she ran. Instead I tell them what I have in common with them. I write about Catholics, sort of like Alice McDermott but with a bit more of an edge.Read More »

“Doubleplusungood” – NORML’s Prisoners of War on the Front Lines of Sentencing Reform

In the early nineties, a woman from Alabama, responding to a prisoner survey conducted by the National Organization for the Reform of Marijuana Laws (NORML) on behalf of her incarcerated husband mused, “…someday, [marijuana] will be legal. Maybe there will be a lot of non-violent people released from the Government and bac [sic] to their families.” The statement has proven remarkably prescient, as recent events surrounding both legalization and sentencing reform have shown. It is also clear that despite these promising new steps, obstacles and controversy remain.

marijuana_map.0.0
We’re getting there

On January 12, 2016, Wendell Callahan brutally murdered his ex-girlfriend and her two children in Columbus Ohio. The story in The Columbus Dispatch quickly informed readers that Callahan had “twice benefited” from retroactive reductions in federal sentencing guidelines. This was in reference to a 2014 decision by the U.S. Sentencing Commission, an independent commission in the judiciary, to first reduce federal sentences for non-violent drug offenses, and later under intense public pressure, to make these changes retroactive.

Read More »

Fiction Points: Mira Gonzalez

miragonzalez
Mira  Gonzalez (credit: her Tumblr)

Mira Gonzalez is the author of the poetry collection i will never be beautiful enough to make us beautiful together (2013) and Selected Tweets (2015), a collaborative double-book with recent Fiction Points interviewee Tao Lin. Her work has appeared in Vice, Hobart, MuuMuu House, The Quietus, and elsewhere. Gonzalez’s poems, tweets, essays, and musings are also available for your reading pleasure on her Tumblr page, at Thought Catalog, and in the two drug-infused columns she writes for Broadly. In 2014, i will never be beautiful enough… made the shortlist for the Believer Poetry Award; Flavorwire named Gonzalez among its “23 People Who Will Make You Care About Poetry in 2013,” and her book has been reviewed by The RumpusNylon, Vice, and other publications. Gonzalez lives in Brooklyn and hails from Los Angeles.

Two nuns and a penguin approach you at a bar, and you tell them you’re a writer. When they ask you what you write about, how do you answer?
I would probably be too confused by the penguin in a bar and concerned that my writing would offend the nuns to even tell them my name. I get worried about offending people. I want everybody to like me.
Points is a blog primarily for drug and alcohol historians. What do you think this audience would find most interesting about your work?
I mean, if drugs and alcohol are what they find most interesting then I guess they would be most interested in my drug and alcohol use, particularly my use of less common drugs such as DMT. Or, I guess what I’m saying is that if I were an alcohol and drug historian, I would be most interested in less common, particularly psychedelic drugs, such as DMT.

Read More »